Advertisement

Topics

Hanmi Pharmaceutical co., Ltd. Company Profile

01:48 EDT 22nd June 2018 | BioPortfolio

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting biologics including weekly Insulin, weekly to monthly GLP-1, and their combination for diabetes and obesity (collectively referred as Quantum Project), the novel targeted anti-cancer drugs with improved tolerance and safety profile and fixed-dose combination drugs. For more detail about the company, visit http://www.hanmipharm.com.


News Articles [283 Associated News Articles listed on BioPortfolio]

Lilly Halts Hanmi BTK Inhibitor Trial For RA, Mulls Other Indications

Hanmi Pharmaceutical shares fell sharply on the news Lilly has halted Phase II trials of the South  Korean firm’s BTK...  

Janssen will conduct clinical trials for Hanmi Pharmaceutical's diabetes drug

A diabetes biologic drug developed by South Korea-based Hanmi Pharmaceutical will soon begin clinical trials.  -More- 

Hanmi invests in ‘smart plant’ to boost CDMO biz

South Korean firm Hanmi Pharmaceutical has invested 150bn won ($140.7m) in a manufacturing âsmart plantâ to increase its contract services.

Hanmi gives up on Olita late into development

South Korean pharma firm Hanmi Pharmaceutical has discontinued any further development efforts on Olita,…

Lilly axes trial of Hanmi's arthritis drug

Eli Lilly has opted to end a phase 2 rheumatoid arthritis (RA) trial of a drug it is developing with Korea’s Hanmi Pharmaceuticals, according to press reports. The Korea Biomedical Review cited a r...

Hanmi terminates lung cancer drug after being muscled out by AZ's Tagrisso

South Korea’s Hanmi Pharmaceutical has announced its intention to terminate development of its lung cancer drug Olita (olmutinib) as it admits that circumstances within the space have meant that con...

Eli Lilly and Hanmi Shutter a Failed Phase II RA Trial

Eli Lilly and its Korean collaborative partner Hanmi stopped a Phase II trial on an experimental rheumatoid arthritis treatment following less-than-stellar interim results.

Lilly dumps Hanmi’s rheumatoid arthritis med

Eli Lilly and Hanmi signed an exclusive licensing and collaboration agreement to develop the Bruton’s tyrosine kinase (BTK) inhibitor, HM71224, for the treatment of various autoimmune and other dise...

PubMed Articles [460 Associated PubMed Articles listed on BioPortfolio]

Pharmaceutical cocrystals as an opportunity to modify drug properties: From the idea to application. A review.

The properties of many drugs which have been available on the pharmaceutical market for a long time still need to be improved. Cocrystals are the solid state drug modification which can improve such p...

Total Health-related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers.

This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan.

Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the...

Applications of various analytical techniques in quality control of pharmaceutical excipients.

Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...

The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis.

The non-medical use (NMU) of pharmaceutical drugs is an increasing public health concern. This systematic review consolidates current knowledge about how pharmaceutical drugs are obtained for NMU and ...

Clinical Trials [300 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients

Companies [1031 Associated Companies listed on BioPortfolio]

Hanmi Pharmaceutical co., Ltd.

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting ...

Pharmaceutical Online

Pharmaceutical Online, the pharmaceutical manufacturing industry’s leading Web site. Our online community serves the product-sourcing and information-seeking needs of pharmaceutical professionals wo...

Cypress Pharmaceutical, Inc.

Cypress Pharmaceutical, Inc., founded in 1993, is a specialty pharmaceutical company that develops, markets and distributes generic prescription pharmaceutical products to leading...

P V S P H A R M A

Our Pharmaceutical products solution is focused to help manage the success of client’s business. We thrive on our innovative methodology to provide solution at an unmatched time to delivery and pr...

BESTPHARMAJOBS.CA

Bestpharmajobs does not charge any hidden fees, allowing pharmaceutical professionals to search pharmaceutical jobs, biotech jobs, medical sales, pharmaceutical sales jobs and be seen by potential pha...

More Information about "Hanmi Pharmaceutical co., Ltd." on BioPortfolio

We have published hundreds of Hanmi Pharmaceutical co., Ltd. news stories on BioPortfolio along with dozens of Hanmi Pharmaceutical co., Ltd. Clinical Trials and PubMed Articles about Hanmi Pharmaceutical co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hanmi Pharmaceutical co., Ltd. Companies in our database. You can also find out about relevant Hanmi Pharmaceutical co., Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record